Q4 2018 Collegium Pharmaceutical Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Q4 2018 Collegium Pharmaceuticals, Inc. Earnings Conference Call. (Operator Instructions) Also, as a reminder, this conference call is being recorded. At this time, I'd like to turn the call over to your host, to Alex Dasalla, Head of Investor Relations. Please go ahead.
Welcome to the Collegium Pharmaceutical Fourth Quarter 2018 Earnings Conference Call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by Joe Ciaffoni, our Chief Executive Officer; Paul Brannelly, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.
Before we begin today's call, we want to remind participants that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995.
You are cautioned that such forward-looking statements involve risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
